trial

TMS Enhancement of Visual Plasticity in Schizophrenia

NCTId NCT03220438
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 17 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2019-07-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
17 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2017-09-27
Primary completion
2019-07-16
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Transcranial Magnetic Stimulation

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Investigators

1
Laura M Rowland, PhDPrincipal Investigator

Sites

1 total
Baltimore, United States

Facts & assertions

4 sourced
Enrollment
17
Phase
NA
Primary Completion Date
2019-07-16
Status
TERMINATED
relationships
The graph out of here
drug
Transcranial Magnetic Stimulation
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Laura M Rowland, PhD
person